Cipher Pharmaceuticals Inc (CPH_TSE)
CPH_TSE moved a median of -0.35% 30 minutes after news, and +0.91% by the close. How CPH_TSE actually reacts to news — the realized, point-in-time move the market made, measured across 43 labeled events over the last three years with zero look-ahead.
CPH_TSE’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 31% | 13 |
| 30-min | -0.35% | 43% | 14 |
| 60-min | -0.49% | 43% | 14 |
| to close | +0.91% | 57% | 14 |
| Middle 50% of CPH_TSE reactions | -2.21% to +0.31% |
|---|---|
| Median reaction (30-min) | -0.35% |
| Measured reactions | 43 |
Half of all Cipher Pharmaceuticals Inc news events land between -2.21% and +0.31% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when CPH_TSE moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to CPH_TSE's baseline. Nothing else.
Recent CPH_TSE events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Cipher Pharmaceuticals Announces the Appointment of Rajiv De Silva to its Board of Directors | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Reports Second Quarter 2026 Results | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Schedules Q2 2026 Earnings Release and Conference Call | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals and the pan-Canadian Pharmaceutical Alliance (pCPA) Sign Letter of Intent for Public Drug Plan Coverage of Epuris® | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Announces Results of Annual General Meeting of Shareholders | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Reports First Quarter Results | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Announces Normal Course Issuer Bid | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Schedules Q1 2026 Earnings Release and Conference Call | Press release | Canada Newswire | — | — | |
| CaryHealth Launches Direct-to-Patient Program for Cipher Pharmaceuticals’ Natroba™ (spinosad) | Press release | Business Wire | — | — | |
| Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba™ (Spinosad) | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Reports Third Quarter 2025 Results | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Receives Successful Arbitration Award | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Announces the Passing of Director Mr. Harold Wolkin | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Schedules Q2 2025 Earnings Release and Conference Call | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Reports First Quarter 2025 Results, and Announces $15 Million Debt Repayment | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Schedules Q1 2025 Earnings Release and Conference Call | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Announces Normal Course Issuer Bid, Including Intention to Utilize Block Purchases | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Secures Medicaid Step-Through Preferred Status for Natroba™ in the state of Illinois | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Schedules Q4 & Fiscal 2024 Earnings Release and Conference Call | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Partner Moberg Pharma AB Reports Topline Data in MOB-015 Phase 3 Study | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Reports Third Quarter 2024 Results | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Schedules Q3 2024 Earnings Release and Conference Call | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals Enhances Leadership Team with Appointment of New Chief Business Officer | Press release | Canada Newswire | — | — | |
| Cipher Pharmaceuticals to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024 | Press release | Accesswire | +0.41% | -0.89% | |
| Canadian Investment Regulatory Organization Trade Resumption - CPH | Press release | Canada Newswire | +0.57% | +11.18% | |
| Canadian Investment Regulatory Organization Trading Halt - CPH | Press release | Canada Newswire | -2.23% | +6.00% | |
| Cipher Pharmaceuticals Partner Moberg Pharma AB Provides Update on MOB-015 Phase 3 Study | Press release | Canada Newswire | -2.42% | -0.13% | |
| Cipher Pharmaceuticals Reports Second Quarter 2024 Results | Press release | Canada Newswire | -0.21% | +3.22% | |
| Cipher Pharmaceuticals Schedules Q2 2024 Earnings Release and Conference Call | Press release | Canada Newswire | +0.00% | -1.38% | |
| Cipher Pharmaceuticals Acquires Profitable Growth Dermatology Products from ParaPRO for US$89.5 Million | Press release | Canada Newswire | +10.20% | +11.05% | |
| Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders | Press release | Canada Newswire | — | -0.70% | |
| Cipher Pharmaceuticals Announces Change of Auditor | Press release | Canada Newswire | +0.00% | +0.64% | |
| Cipher Pharmaceuticals Announces Normal Course Issuer Bid | Press release | Canada Newswire | -0.18% | -0.92% | |
| Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023 | Press release | Canada Newswire | -0.60% | +3.00% | |
| Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference Call | Press release | Canada Newswire | +0.00% | -2.24% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the CPH_TSE section they belong to.
Where else CPH_TSE is measured.
CPH_TSE earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Eiger BioPharmaceuticals, Inc. (EIGR) | 45 | -1.57% | 32% |
| OTSUKA HOLDINGS CO ADR (OTSKY) | 45 | -0.06% | 39% |
| Navidea Biopharmaceuticals, Inc. (NAVB) | 43 | +5.93% | 82% |
| POLYDEX PHARMS LTD (POLXF) | 43 | 0.00% | 35% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Cipher Pharmaceuticals Inc's median reaction calculated?
Every labeled CPH_TSE news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 43 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 43% of CPH_TSE's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does CPH_TSE's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.